论文部分内容阅读
目的对肺癌化疗患者服用复方皂矾丸防治贫血的临床疗效进行观察。方法 60例肺癌患者作为研究对象,按照随机分配原则分为治疗组和对照组,每组30例。治疗组患者采用吉西他滨联合顺铂(GP)方案进行化疗并同时服用复方皂矾丸,对照组患者单纯采用GP方案进行化疗,观察并比较两组患者的临床治疗效果。结果治疗前,两组血红蛋白及白细胞水平比较差异无统计学意义(P>0.05);治疗后,治疗组患者血红蛋白及白细胞水平均显著高于对照组,差异具有统计学意义(P<0.05)。治疗组不良反应发生率3.33%明显低于对照组20.00%,差异具有统计学意义(P<0.05)。结论肺癌化疗患者服用复方皂矾丸防治贫血疗效确切,安全可靠,值得在临床上积极推广。
Objective To observe the clinical efficacy of compound Zaofan pills in preventing and curing anemia in patients with lung cancer chemotherapy. Methods Sixty patients with lung cancer were divided into treatment group and control group according to the principle of random distribution, with 30 cases in each group. Patients in the treatment group were treated with gemcitabine combined with cisplatin (GP) regimen while taking compound Zaofan Pills. Patients in the control group were treated with GP alone. The clinical effects of the two groups were observed and compared. Results Before treatment, the levels of hemoglobin and leukocyte in the two groups had no significant difference (P> 0.05). After treatment, the levels of hemoglobin and leukocyte in the treatment group were significantly higher than those in the control group (P <0.05). The incidence of adverse reactions in the treatment group was significantly lower than that in the control group (3.33% vs 20.00%, P <0.05). Conclusion The patients with lung cancer chemotherapy taking compound Zaofan Pill have definite curative effect in prevention and treatment of anemia and are safe and reliable. It is worth to be actively promoted in clinic.